iMed.ULisboa Investigator received the “CRS Immuno Delivery Young Investigator Award 2020” 1
June 2020

iMed.ULisboa Investigator received the “CRS Immuno Delivery Young Investigator Award 2020”

Helena Florindo, leader of the BioNanoSciences – Drug Delivery and Immunotherapy group at iMed.ULisboa received the “CRS Immuno Delivery Young Investigator Award 2020”, by the Focus Group on Immunology of the international Controlled Release Society (CRS), following her contributions in the drug delivery field. This distinction recognizes her work focused on the development of novel nanotechnology-based vaccines for cancer treatment. Helena Florindo will present the major findings of her team on the impact of these new nanovaccines on the regulation of immune function against cancer, on June 30th 2020, at the annual (online) meeting of this society.